About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. María Soler Artigas, is a main researcher Psychiatry, Mental Health and Addictions in Vall d'Hebron Research Institute (VHIR)
Abstract: Attention Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental disorder characterized by a persistent pattern of inattentive, hyperactive, and impulsive behaviors, which increases the risk of health problems, psychiatric co-morbidities, social disability, academic and occupational failure, and risk behaviours throughout the individual’s life. ADHD is highly heritable, although a large proportion of its heritability still needs to be explained. Gene expression, which results from the interplay between genetic and environmental factors, may help to elucidate additional phenotypic variance. In addition, most of its comorbidities are also highly heritable, with genetic risk factors being involved not only in their individual etiology but also in their co-occurrence.
This presentation will focus on a genetic approach to elucidate causal relationships between two traits, Mendelian randomization, and its application to ADHD and co-occurring traits and will also show the results of a study which integrates genetic and gene expression data to improve prediction of ADHD.
Host: Dr. Marta Ribasés Haro, Main researcher Psychiatry, Mental Health and Addictions in Vall d'Hebron Research Institute (VHIR)
Registre Online: https://gencat.zoom.us/j/94627693882
